UNSPSC 51201650: Zoster vaccine

A live attenuated virus vaccine indicated for prevention of herpes zoster (shingles) in individuals 50 years of age and older

UNSPSC 51201650 Zoster vaccine is a Commodity code that encompasses immunizations against varicella-zoster virus, though recent state-local solicitation activity under this code shows minimal volume and a mismatch with the code's nominal scope. The Mississippi State Department of Health posted a sole-source notice in July 2026, but that opportunity concerns Yellow Fever Vaccine from Sanofi Pasteur, Inc.—a different vaccine class entirely—rather than zoster vaccine. State and local health departments are the primary issuing bodies for vaccine procurement, typically through health offices or purchasing divisions within state departments of health.

The code shows little recent relevant activity. The sole documented opportunity is the Mississippi State Department of Health's Yellow Fever Vaccine procurement (Notice 1301-27-R-RFIN-00001, due August 3, 2026), which falls outside zoster vaccine scope. No details on quantity, contract term, or estimated value are specified in the notice. Geographic and issuing-body characterization cannot be drawn from a single misaligned opportunity; the code's activity profile remains unclear based on current market signals.